Frontage Holdings P/S 2024

Frontage Holdings Aktienanalyse

What does Frontage Holdings do?

Frontage Holdings Corp is an international pharmaceutical and biotechnology company founded in 2001 in Pennsylvania, USA. With its wide range of services in preclinical and clinical research, Frontage offers its customers innovative and cost-effective solutions to accelerate and optimize the development of new therapeutics and drug candidates. The core business of Frontage focuses on providing services in the areas of pharmacology, pharmacokinetics, toxicology, preclinical development, clinical development, and bioanalytical laboratory services. The company operates research laboratories in the USA and China and has extensive experience in collaborating with customers from the pharmaceutical and biotechnology industry, as well as academic institutions. Frontage has become a major pharmaceutical and biotechnology company serving customers in the USA, Europe, and Asia. As such, Frontage has become a key partner for companies looking to advance their drug candidates through the clinical phases of development. Frontage offers targeted and tailored services to meet the requirements of each project and can support customers in the rapid and cost-effective implementation of their goals. The various divisions of Frontage include pharmaceutical services, chemical development, bioanalysis, and DMPK (Disposition, Metabolism, Pharmacokinetics). Frontage's pharmaceutical services offer a wide range of preclinical and clinical development resources, including cell-based assays, drug metabolism and pharmacokinetic studies, as well as clinical trial management and execution. Frontage's chemical development division provides a wide range of expert services, including the synthesis of organic molecules, process development, and scalable production. Frontage's bioanalytical services offer a range of solutions for the quantitative determination of drugs and other biomolecules in biological samples such as blood and urine. This includes the use of advanced technologies such as mass spectrometry for compound identification and quantification. DMPK is an important division of Frontage, focusing on the absorption, metabolism, distribution, and excretion of drugs in the body and their occurrence in biological fluids such as blood and urine. Frontage utilizes its expertise in DMPK to help its customers optimize drug concentrations in the bloodstream and achieve optimal efficacy. Frontage has continuously expanded its services to meet the growing demands of the industry. The company has also focused on providing innovative technologies that can enhance the efficiency and accuracy of research and development. Frontage works closely with its customers to develop customized solutions that meet their specific requirements. Frontage has a proud history as a trusted partner in the pharmaceutical and biotechnology industry, offering its customers high-quality and reliable services. Through its effective and innovative research and development, Frontage supports its customers in the development of drugs that can help improve the lives of people worldwide. Frontage Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Frontage Holdings's P/S Ratio

Frontage Holdings's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Frontage Holdings's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Frontage Holdings's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Frontage Holdings’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Frontage Holdings Stock

What is the price-to-earnings ratio of Frontage Holdings?

The price-earnings ratio of Frontage Holdings is currently 0.92.

How has the price-earnings ratio of Frontage Holdings changed compared to last year?

The price-to-earnings ratio of Frontage Holdings has increased by -57.6% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Frontage Holdings high compared to other companies?

Yes, the price-to-earnings ratio of Frontage Holdings is high compared to other companies.

How does an increase in the price-earnings ratio of Frontage Holdings affect the company?

An increase in the price-earnings ratio of Frontage Holdings would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Frontage Holdings affect the company?

A decrease in the price-earnings ratio of Frontage Holdings would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Frontage Holdings?

Some factors that influence the price-earnings ratio of Frontage Holdings are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Frontage Holdings pay?

Over the past 12 months, Frontage Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Frontage Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Frontage Holdings?

The current dividend yield of Frontage Holdings is .

When does Frontage Holdings pay dividends?

Frontage Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Frontage Holdings?

Frontage Holdings paid dividends every year for the past 0 years.

What is the dividend of Frontage Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Frontage Holdings located?

Frontage Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Frontage Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Frontage Holdings from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did Frontage Holdings pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Frontage Holdings in the year 2023?

In the year 2023, Frontage Holdings distributed 0 USD as dividends.

In which currency does Frontage Holdings pay out the dividend?

The dividends of Frontage Holdings are distributed in USD.